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BACKGROUND: To guide anesthetic administration with electroencephalogram moni-
tors in children, an adequate characterization of the anesthetic effect measured by
these monitors in this population is needed. We sought to quantify and compare
the dynamic profile of sevoflurane’s effect measured with the cerebral state index
(CSI) and the bispectral index (BIS) in children.
METHODS: Fifteen healthy children, aged 3–15 yr, scheduled to undergo minor
surgery were prospectively studied. During the simultaneous recording of CSI and
BIS, the sevoflurane vaporizer was set at 6 vol % for 5 min and then decreased.
End-tidal concentrations (CET) were measured. The CET–sevoflurane effect–site
concentration equilibration and pharmacodynamics were modeled. Goodness of fit
between models was compared. Data are typical value (coefficient of variation).
RESULTS: Within the anesthetic depth range studied, the rate of change of sevoflu-
rane’s effect expressed as the effect–site equilibration half-life (t1/2 ke0) was slower
with the CSI [2.0 (14) min] than with BIS [1.2 (53) min] (P  0.05). The estimated
baseline effect of BIS and CSI before sevoflurane administration (E0) was 84 (39) for
CSI and 87 (7) for BIS (NS). The sensitivity to sevoflurane hypnotic effect expressed
in the C50 [steady-state CET eliciting half of the maximum response (Emax)] was 2.1
(68) % with CSI and 2.1 (16)% with BIS (NS). The Emax with CSI 45 (0) was higher
than that with BIS 27 (39) (P  0.05). The population prediction error was
significantly better for BIS (0.7  26.9) than for CSI (3.0  178.6) (P  0.05).
CONCLUSIONS: In children, the t1/2 ke0 of sevoflurane and the pharmacodynamics of
sevoflurane were quantified and the results were entirely dependent on the
monitor used to measure its hypnotic effect. Within the anesthetic depth range
studied, the rate of change of sevoflurane’s effect was slower with the CSI. To
adequately guide sevoflurane administration with these monitors in children, these
differences should be considered.
(Anesth Analg 2008;107:1573–8)
The bispectral index (BIS) monitor (Aspect Medical
Systems, Newton, MA) and the cerebral state monitor
(CSM Danmeter A/S, Odense, Denmark) are electro-
encephalogram (EEG) devices that have been used to
guide anesthetic administration in children.1–4 Using
their own algorithms,5,6 which were derived from
adult EEG data, these monitors calculate indices that
can range from 100 (fully awake) to 0 (isoelectric EEG).
Different EEGmonitors have been shown to behave
differently under similar anesthetic conditions.7,8 There-
fore, an adequate characterization of the effect mea-
sured by each device is mandatory before using them
as tools to guide anesthetic administration. This effect
can be studied during nonsteady-state conditions
through the application of an effect compartment
model.9 With this approach, it is possible to character-
ize both the effect–site concentration (Ce) versus effect
relationship and the speed of onset and offset of the
anesthetic action measured with these monitors.
Sevoflurane is the most frequently used inhaled
anesthetic for induction of anesthesia in children. The
aim of this study is to quantify and compare the
dynamic profile of sevoflurane’s effect measured with
the cerebral state index (CSI) calculated by the CSM
and BIS in children.
METHODS
After local ethics committee approval (Facultad de
Medicina, Pontificia Universidad Cato´lica, Santiago,
Chile), informed written consent was obtained from
the parents of all patients. Fifteen ASA I children, aged
3–15 yr, were prospectively studied from December
2006 to March 2007. All patients were scheduled to
undergo elective surgery under general anesthesia
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and did not receive any premedication. Exclusion
criteria were any known central nervous system dis-
ease, recent administration (48 h) of any drug acting in
the central nervous system, and any known adverse
effect to the study drug.
In the operating room, standard monitoring was
applied. At this time, the pediatric sensors of the
Aspect A-2000 BIS® monitor (version XP) and the
standard electrodes of the CSM model 2 monitor were
placed on each patient according to the manufactur-
ers’ recommendations. The smoothing time period of
the BIS monitor was set at 15 s. BIS values were
automatically recorded and transferred to computer
hard disk for off-line analysis using the Hyperterminal
(Microsoft, Redmond, VA) program. The CSM up-
dates the CSI every 1 s and has a fixed smoothing time
of around 10 s.10 The CSI data were recorded using the
Danmeter A/S CSM capture V2.02 onto the computer
hard disk. The BIS and the CSI were recorded simul-
taneously during the study period.
The Datex Capnomac monitor (GE Healthcare,
Helsinski, Finland) was used to measure sevoflu-
rane end-tidal concentrations (CEtsevo). Measure-
ments were automatically registered every 10 s
throughout the study period and transferred to
computer hard disk using the software program
Hyperterminal (Microsoft).
Before sevoflurane administration, a 1-min baseline
period was recorded. During this period, patients
were kept undisturbed and spontaneously breathing
through a facemask. During the transition period,
fresh gas flow (100% oxygen) was maintained at 5
L/min, the mask was manually sealed as tight as
possible, and ventilation was assisted to maintain
end-tidal carbon dioxide concentrations between 30
and 35 mm Hg. The sevoflurane vaporizer was turned
to 6% for 5 min or until burst suppression (BS) 80%.
Immediately after, the vaporizer was turned-off until
BIS returned to values 60. At this point, the study
was finished and anesthesia continued according to
the anesthesiologist’s criteria.
Before starting the recording of CSI and BIS data,
the time of both monitors was synchronized. Pairwise
CSI and BIS data obtained every 5 s was used in the
subsequent analysis. The baseline awake BIS and CSI
values (mean  sd) were calculated using data re-
corded before sevoflurane administration. The data
were judged adequate for baseline calculations if the
signal quality index of BIS and CSI was 20% for 30 s.
To study the relationship between sevoflurane con-
centrations in the effect compartment (Cesevo) and the
corresponding BIS or CSI values, it was assumed that
CETsevo reflected its plasma concentration (Cp) and
that Cesevo was linearly linked to Cp. Cesevo was
estimated as:
dCe
dt
 Ke0  (CETsevo Cesevo) (1)
where the ke0 is the first-order CETsevo versus Cesevo
equilibration rate constant. The Ce over time were
calculated as the convolution of the predicted plasma
concentrations over time with the disposition function
of the effect site. The convolution was based on a
“connect the dots” approach, previously used by
Schnider et al.11 The ke0 was estimated by minimizing
the area of the hysteresis loop of either EEG index data
versus Cesevo. The mathematical approach can be
found elsewhere.12
The relation between Cesevo and BIS or CSI was
modeled using a sigmoidal Emax model:
Effect  E0  (Emax  E0)
Cesevo

Ce50sevo
  Cesevo
 , (2)
where effect is the measured BIS or CSI value, E0
is the baseline measurement when no drug is
present, Emax is the maximum possible drug effect,
Cesevo is the calculated effect–site concentration of
sevoflurane, Ce50sevo is the effect–site concentration
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Figure 1. Time course of measured bispectral index (BIS),
cerebral state index (CSI), and end-tidal sevoflurane concen-
trations for each patient.
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associated with 50% maximal drug effect, and  is
the steepness of the concentration–response relation
curve. The model parameters were estimated using
NONMEM V (Globomax LLC, Hanover, MD).13
Interindividual variability was assumed to have a
log-normal distribution:
Pi  Ptv ei (3)
where Pi is the parameter value (Ke0, E0, Emax, , or
Ce50) in the ith patient, Ptv is the typical value of the
parameter in the population, and  is a random
variable with a mean of 0 and a variance of 2.
Individual variability is reported as , the sd of  in
the log domain, which is approximately the coefficient
of variance in the standard domain. Residual intrain-
dividual variability was modeled using a standard
additive error model.
The goodness of the model fit was evaluated. We
calculated the population prediction error (PE) be-
tween the observed values and post hoc Bayes pre-
dicted values for BIS and CSI and the absolute median
prediction error (MDAPE) for each patient.14 Differ-
ences between both indices for PE and MDAPE were
tested using a Student’s t-test.
Normality of data was tested with the Kolmogorov–
Smirnov test. Comparisons between monitors were
performed with paired Student’s t-test or Wilcoxon’s
signed rank test. A P value 0.05 was considered
statistically significant. Statistical analyses were per-
formed using R (language and environment for statis-
tical computing, freely available from http://www.
r-project.org/). Data are mean  sd (range) or typical
value (coefficient of variation).
RESULTS
All patients, 7 female and 8 male, age 8.1  3.6
(3.6 –15.0), weight 35.3  15.9, (16–65), and height
131  23 (97–168), completed the study. No conflict
in the positioning of the two sensors was observed.
Adequate airway management was obtained in all
patients without requiring insertion of an oral
airway. Peripheral oxygen saturation was main-
tained above 95% throughout the study period in all
children.
Measured awake BIS and CSI values were 91.7 
4.4 and 89.2  10.4, respectively (NS). Awake CSI
values ranged from 100 to 63 showing a wider disper-
sion than BIS (98–80). During the baseline period,
the maximum levels of electromyographic (EMG)
activity were recorded in both monitors, CSM (96%
 10%) and BIS (48%  3%) (P  0.05). The signal
quality index was 20% in both monitors during
this period. The minimum BIS and CSI values
observed during the study period were 10.8  5.8
and 36.9  1.1, respectively (P  0.05). No BS
activity was recorded by the BIS or CSI monitors
throughout the study period.
Figure 1 shows the time course of BIS, CSI, and
CETsevo for each patient. The hysteresis loop between
BIS, CSI, and CETsevo is shown in Figure 2. A sigmoid
Emax model could be fitted to the data of all patients.
The rate of change of sevoflurane’s effect expressed
as the t1/2 ke0 was slower with the CSI [2.0 (14) min]
than with BIS [1.2 (53) min] (P  0.05). The param-
eter values estimated with each monitor are in Table
1. We were unable to estimate the variance for some
of the parameters. The residual error for each model
(as a measure of the intraindividual variability in
the log domain) was 9.45 for BIS and 11.05 for CSI.
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Figure 2. Relationship between the in-
dividual measured bispectral index
(BIS) and cerebral state index (CSI)
values versus the measured sevoflu-
rane end-tidal concentrations. The
hysteresis in the relationship is re-
vealed in both plots.
Table 1. Parameters Estimated with Each
Electroencephalogram Monitor
CSI BIS
E0 84 4 (39) 87 1 (7)
Emax 45 9 27 17 (39)*
Ce50 (%) 2.1 8 (68) 2.1 0 (16)
 6.9 45 5.4 14
t1/2 ke0 (min) 2.0 19 (14) 1.2 0 (53)*
Results from the population model are presented as parameter estimates, together with the
corresponding relative standard error of the estimate RSE%. RSE are calculated as the ratio
between the standard error and the estimate of the parameter. Interindividual variability is
expressed as coefficient of variation (CV%).
BIS  bispectral index; CSI  cerebral state index.
*P  0.05.
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The relations between the observed and the post hoc
Bayesian predicted BIS and CSI versus Cesevo are
plotted in Figures 3 and 4. With increasing Cesevo, both
BIS and CSI decreased.
The goodness of the model fit was first analyzed by
observing the relation between observed and post hoc
Bayesian predicted values of BIS and CSI. As observed
in Figure 5, a smaller scatter was observed for BIS than
for CSI. The population PE was significantly better for
BIS (0.71  26.9) than for CSI (2.95  178.62) (P 
0.05). The MDAPE for BIS (12.09  4.47) and for CSI
(14.10  4.87) were similar (P  0.24).
DISCUSSION
This study quantified and compared the relationship
between CETsevo and BIS or CSI during sevoflurane
anesthesia in children. The major finding of this study is
that the parameters of the pharmacokinetic and pharma-
codynamic model were entirely dependent on the moni-
tor used to measure sevoflurane’s effect.
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Figure 3. Observed raw bispectral index (BIS) data of all patients versus sevoflurane effect–site concentration (Cesevo). (A)
Sigmoid Emax model of the BIS versus Cesevo. (B) The thin lines represent individual patient fits, whereas the bold line
represents the typical curve of the population data. BIS progressively decreased when Cesevo concentrations increased from
0% to 3%. At higher Cesevo (3%–5%), BIS tended to stabilize in values lower than 40.
Predicted
0 1 2 3 4 5 6
C
S
I
Observed
Sevoflurane effect site concentration (%)
0 1 2 3 4 5 6
C
S
I m
ea
su
re
d
0
20
40
60
80
100 A B
Figure 4. Observed raw cerebral state index (CSI) data of all patients versus sevoflurane effect site concentration (Cesevo). (A)
Sigmoid Emax model of the CSI versus (Cesevo). (B) The thin lines represent individual patient fits, whereas the bold line
represents the typical curve of the population data. CSI progressively decreased when Cesevo concentrations increased from
0% to 3%. At higher Cesevo (3%–5%) CSI tended to stabilize in values of around 40.
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The t1/2 ke0 in this study not only represents
sevoflurane’s end-tidal to brain equilibration time, but
also the time delay of the index used to measure
sevoflurane’s effect. In a study using simulated EEG
signals, Pilge et al.15 showed that all currently avail-
able EEG indices had different time lags to react to a
change in the level of anesthesia. The authors also
showed that these delays were not constant, and that
they varied depending on the depth of anesthetic level
and on whether this level was increasing or decreas-
ing. The response measured by these monitors and
the computational delays involved in the calculation
of the corresponding EEG indices will influence the
t1/2 ke0. In the present study, the lower t1/2 ke0
estimated with BIS indicated faster on and offset
times for the response measured with this monitor
compared with the response measured by the CSM.
This finding is consistent with Pilge et al.’s results,
where time delays of BIS tended to be shorter than
CSI delays when intermediate ranges of anesthetic
depth were simulated.15
The Ce versus effect relationship for sevoflurane
was also found to be influenced by the monitor used
to measure its hypnotic effect. Although BIS and CSI
are both ordinal scales, these variables were treated as
continuous data in the model analysis. This assumes
that changes in these indices represent a relative
change in the magnitude of hypnosis. Both indices
showed similar awake values with a wider dispersion
observed in the CSI. With this last index, values
indicative of sedation were observed in some patients
before sevoflurane administration. Both BIS and CSI
then progressively decreased during sevoflurane in-
duction (Fig. 1). However, BIS showed a more pro-
nounced and less variable decrease compared with
CSI (Figs. 3 and 4, respectively). At deeper anesthetic
levels (Cesevo 3%), both indices tended to stabilize,
but BIS reached lower Emax values than CSI, which
showed a plateau around 40. This plateau might be
explained because the CSI does not include frequen-
cies below 6 Hz in its algorithm.6 Therefore,  waves,
typically present during deep anesthesia, are not
detected by the CSI, leading to poor correlation with
the Cesevo until BS is observed. This is particularly the
case in this study, as no BS was observed. It has been
shown that the CSI can decrease below 40 if BS is
registered but is very unlikely to do so if no BS is
observed.6,8
EMG activity can contaminate EEG signals and
might alter the value of EEG-derived indices. In our
study, high levels of EMG activity were recorded
during the baseline period and at the beginning of the
induction period. The wide range of CSI values ob-
served during baseline and during light anesthesia
suggests that this index is highly affected by EMG
activity. In addition, there is a new pediatric BIS
sensor with four electrodes (not used in the current
study) that is supposed to better detect and discard
artifacts in the signal, improving the performance of
this monitor, especially during light anesthesia.
Since BIS is currently considered a useful tool to
guide anesthetic doses in children 1 yr,1 we de-
cided to include a broad age range to increase the
general applicability of our results. It can be argued
that the age range chosen was too wide and that age
changes in EEG might be influencing our results.16
However, it has been described that awake BIS
values in children between 1 and 15 yr are close to
values reported in adult patients and that the BIS
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Figure 5. Scatter plot of the observed versus individual predictions (post hoc Bayesian estimates) values of bispectral index
(BIS) and cerebral state index (CSI). The solid line represents the identity line. The adequacy of the structural model is
corroborated (observed vs individual predictions data lie very close to the identity line).
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response during emergence from sevoflurane anes-
thesia is also relatively similar to that reported in
adult studies.17
Another limitation of this study is that clinical
variables of consciousness were not incorporated in
the analysis. However, the relatively long and variable
time delays of all currently available EEG monitors15
limit the applicability of these variables as markers of
imminent loss of consciousness when rapid infusion
schemes of anesthetics are used.18 We think that to
reliably assess clinical end-points and to correlate them
with the corresponding EEG index or Ce, slower induc-
tion rates or steady-state designs are more adequate.
Advisory systems for sevoflurane administration
have been assessed in adult patients showing an
improvement in the titration of this drug.19 Some
future development of an on-line available pharmaco-
dynamic model derived from our results in children
might be useful to guide drug administration in this
population. However, differences in the measured
response by these monitors should be considered.
CONCLUSIONS
In children, the t1/2 ke0 of sevoflurane and the
pharmacodynamics of sevoflurane were quantified
and the results entirely depended on the monitor used
to measure its hypnotic effect. Within the anesthetic
depth range studied, the rate of change of sevoflu-
rane’s effect was slower with the CSI. To adequately
guide sevoflurane administration with these monitors
in children, these differences should be considered.
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